Exhibit 99.1
Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC
| Date | Principal | Aggregated Principal | ||||||||
| Original Secured Promissory Note | 11/10/2022 | $ | 2,319,279 | $ | 2,319,279 | |||||
| Additional Loans to be included: | ||||||||||
| Loans #1 dated 12/22/2022 through Loans #50 dated 12/31/2025 | $ | 7,075,000 | $ | 9,394,279 | ||||||
| Loan #51 | 1/02/2026 | $ | 100,000 | $ | 9,494,279 | |||||
| Loan #52 | 1/16/2026 | $ | 100,000 | $ | 9,594,279 | |||||
| Loan #53 | 2/06/2026 | $ | 100,000 | $ | 9,694,279 | |||||
| Loan #54 | 2/13/2026 | $ | 100,000 | $ | 9,794,279 | |||||
| Loan #55 | 3/09/2026 | $ | 100,000 | $ | 9,894,279 | |||||
| Loan #56 | 3/30/2026 | $ | 100,000 | $ | 9,994,279 | |||||
| Loan #57 | 4/03/2026 | $ | 100,000 | $ | 10,094,279 | |||||
| Loan #58 | 4/20/2026 | $ | 100,000 | $ | 10,194,279 | |||||
| Loan #59 | 5/05/2026 | $ | 100,000 | $ | 10,294,279 | |||||
| Loan #60 | 5/15/2026 | $ | 100,000 | $ | 10,394,279 | |||||
| Loan #61 | 5/29/2026 | $ | 100,000 | $ | 10,494,279 | |||||
| Loan #62 | 6/24/2026 | $ | 200,000 | $ | 10,694,279 | |||||
| Loan #63 | 7/17/2026 | $ | 200,000 | $ | 10,894,279 | |||||
| Loan #64 | 8/14/2026 | $ | 200,000 | $ | 11,094,279 | |||||
| Loan #65 | 9/18/2026 | $ | 100,000 | $ | 11,194,279 | |||||
| Loan #66 | 10/02/2026 | $ | 100,000 | $ | 11,294,279 | |||||
ACURA PHARMACEUTICALS, INC.
| By: | /s/ Robert A. Seiser |
Robert A. Seiser
Senior Vice President & CFO
Date: October 6, 2026